Billing Deprescribing Interventions: Portrait of an Initiative in Québec, Canada
Open Access
- 2 May 2025
- journal article
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 136 (6) , e70050
Abstract
Background: Deprescribing is a patient‐centred process in which a healthcare professional reduces or stops medications to improve health outcomes. Since late 2022, community pharmacists in Québec, Canada, have been able to bill for deprescribing interventions, enabling more robust deprescribing research in large cohort studies.Objective: This study aimed to assess the prevalence of deprescribing claims in Québec community pharmacies from January 1, 2023, to November 30, 2024, and to identify the most commonly deprescribed medication classes.Methods: We analysed the total number of deprescribing claims submitted by pharmacists during this period and categorized deprescribed medications using the American Hospital Formulary Service classification.Findings: Over 90 000 claims were submitted for deprescribing interventions, with most involving central nervous system medications. Although the number of claims increased over time, the overall volume remained modest.Conclusion: While limitations remain, such as the gradual adoption of billing interventions, Québec's reimbursement model for deprescribing interventions provides an important framework for research, offering a mechanism to study deprescribing in real‐world settings.Keywords
Funding Information
- Natural Sciences and Engineering Research Council of Canada (CPG‐170621)
This publication has 10 references indexed in Scilit:
- BCPT 2023 policy for experimental and clinical studiesBasic & Clinical Pharmacology & Toxicology, 2023
- Revisiting systematic reviews on deprescribing trials to better inform future practice and researchBritish Journal of Clinical Pharmacology, 2023
- How does deprescribing (not) reduce mortality? A review of a meta‐analysis in community‐dwelling older adults casts uncertainty over claimed benefitsBasic & Clinical Pharmacology & Toxicology, 2023
- American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medication use in older adultsJournal of the American Geriatrics Society, 2023
- Methods for evaluating the benefit and harms of deprescribing in observational research using routinely collected dataResearch in Social and Administrative Pharmacy, 2022
- STOPP/START criteria for potentially inappropriate medications/potential prescribing omissions in older people: origin and progressExpert Review of Clinical Pharmacology, 2019
- Potentially inappropriate medications in older adults: a population-based cohort studyFamily Practice, 2019
- Classification systems for drugs and diseases2016
- A systematic review of the emerging definition of ‘deprescribing’ with network analysis: implications for future research and clinical practice.British Journal of Clinical Pharmacology, 2015
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesThe Lancet, 2007